Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234028 | 0.68 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL14628579 | 0.63 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL2123374 | 0.63 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL3420145 | 0.63 | — | — | |
| SCHEMBL6641039 | 0.63 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL177144 | 0.61 | — | — | |
| SCHEMBL1202752 | 0.61 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL18110409 | 0.61 | — | — | |
| SCHEMBL5632597 | 0.61 | — | — | |
| SCHEMBL220955 | 0.60 | YTHDC1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109476663-B | Pyrazolopyridine derivatives for the treatment of cancer | 基因泰克公司 | 2021-11-09 | — | — | CN | disclosed |
| US-8012957-B2 | Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators | JANSSEN PHARMACEUTICA NV (BE) | 2011-09-06 | — | — | US | disclosed |
| US-20070259853-A1 | TETRAHYDRO-1H-1,2,6-TRIAZA-AZULENE CANNABINOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259853-A1 | TETRAHYDRO-1H-1,2,6-TRIAZA-AZULENE CANNABINOID MODULATORS | CNR1, CNR2, GPR18 | MEN1 1647/4885KMT2A 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.